Aratana Therapeutics Inc (NASDAQ:PETX)

4.06
Delayed Data
As of 12:14pm ET
 -0.03 / -0.73%
Today’s Change
3.91
Today|||52-Week Range
7.67
-22.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$175.9M

Company Description

Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs. The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.

Contact Information

Aratana Therapeutics, Inc.
11400 Tomahawk Creek Parkway
Leawood Kansas 66103
P:(913) 353-1000
Investor Relations:
(913) 353-1023

Employees

Shareholders

Mutual fund holders40.09%
Individual stakeholders32.11%
Other institutional31.69%

Top Executives

Steven St. PeterPresident, Chief Executive Officer & Director
Brent A. StandridgeChief Operating Officer
Craig A. ToomanCFO, Treasurer & Head-Investor Relations
Ernst HeinenChief Development Officer
Laura Simon TremlDirector-Drug Development